11 July 2013 - Deborah Wilkes
Archived
Pharmstandard has announced plans to acquire Singapore's Bever Pharmaceutical for US$630 million and spin-off its branded OTC business by early 2014.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.